-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Half of Britons may have been infected with the new coronavirus, according to a study by The Daily Mail of London.
reports that a new modelling study from Oxford University shows that the new coronavirus began spreading in the UK in mid-January, about two weeks before the first confirmed case was reported in the UK and a month before the first death was reported.
researchers at Oxford University believe half of Britons may have been infected with the new coronavirus, according to research.
the Daily Mail, this means it has enough time to spread widely, and many Britons may have gained immunity. Sunatra Gupta, a professor of theoretical epidemiology at
leading the study, said they needed tests to evaluate the theory. 'We need to start large-scale antibody testing immediately to assess where we are in the development of the outbreak, ' mr.
. Gepta said.
reported that the number of confirmed cases in the United Kingdom on the 24th reached a record high, with 1,427 new confirmed cases and a cumulative total of more than 8,000 confirmed cases.
87 new deaths, bringing the cumulative number of deaths to 422.
reported that the number of deaths from new pneumonia in the UK has increased nearly sixfold in a week.
as of last Tuesday, there were just 71 deaths in the UK.
at the same time, the Daily Mail warns that the number of new crown virus infections in the UK could be close to 400,000, thanks to the government's decision to test only patients in hospitals for new coronavirus tests. According
to the latest data released by Johns Hopkins University in the United States, as of 13:52 BST on March 25, the uk had a cumulative total of 8,164 confirmed cases of new crown pneumonia, a cumulative total of 423 deaths.
"Britain implements 'sealing the country' to contain the spread of the new crown pneumonia epidemic," the Financial Times reported on Thursday, in a televised speech on Monday night, saying that people must stay at home, in addition to buying essentials, seeking medical treatment, exercising outdoors (one exercise per day) and having to work as "key workers".
are prohibited from gathering with people who do not live together, not to hold all social events, including weddings (except funerals), and the police have the power to disperse parties and to fine those who do not comply with the relevant regulations.
Johnson's ban announced on Monday night is not a new measure, after the British government has urged people to stay out as little as possible and keep each other at a distance of more than two metres outdoors.
these measures were previously government proposals and were not enforced.
the BBC said the new measures would "save many lives" compared to the previous one.
but some British MPs said the measures were "too late" and that the cost of life was inevitable.
Extended Reading: UK: Uka for joint development of new treatments for new crown pneumonia on March 23, local time, the British Medical Research Council (MRC) announced the first round of funding projects by the Department of Health and Social Welfare and the UK Innovation Foundation (UKRI) to conduct research on the new coronavirus (out of six).
project "Developing Spectrum and Antibodies CoV-bnMABs for the treatment of highly pathogenic coronaviruses, including the new coronavirus" project, led by Imperial College London and attended by Chinese and British scholars, is included.
this is the first joint research project between the UK government and China since the outbreak of New Crown Pneumonia.
outbreak, the Uking House of Government on 4 February allocated 20 million pounds as a quick response fund for the study of the new crown virus, hoping to study the new crown virus and its treatment methods in terms of "active intervention" and "diagnosis and understanding of the new coronavirus".
's organisation and screening of the campaign is shared by the National Institutes of Health on behalf of the UK Department of Health and UKRI.
the main objective of this selected Sino-British cooperation project is to develop a new type of coronavirus broad-spectrum neutralizing antibodies (COV-bnMAB).
antibodies are molecules produced by the body's immune system that can be specifically identified and bound to structures such as the surface of the virus, thereby preventing the virus from invading and instructing the immune system to destroy it.
Imperial College has identified several antibodies that bind not only to the new coronavirus protein, but also to broad-spectrum neutralizing antibodies that bind to other coronaviruses, such as SARS and MARS proteins.
study will use these candidate antibodies to develop a potential antibody therapy and bring it into clinical trials as soon as possible to determine whether it can treat a range of coronavirus infections, including the new coronavirus. "We want to provide antibodies that are different from monoantibodies because they have a broad spectrum, so they can not only fight the new coronavirus currently raging, but also against SARS, MARS and other types of coronaviruses that may occur in the future, so there is a broad prospect of application," Xu Xiaoning, a professor in the department of medicine at Imperial College London, who is leading the project, told Science Daily.
", "There are a number of cases in which critically ill patients have been treated clinically with the special plasma of patients recovering from the new crown pneumonia.
but after all, plasma products have limited sources, and must go through strict blood biosafety testing can be used in clinical, it is difficult to meet the needs of the current epidemic prevention and control.
responsible for the project pre-clinical and clinical development and research tasks of The U.S. Pharmaceutical Biopharmaceutical Technology (Shenzhen) Company, Dr. Yan Jian, said, the application of a new generation of self-established high-throughput all-human B-cell screening technology, from the rehabilitation of the development of the coronavirus-specific widespectrum and antibodies, and then in vitro through genetic engineering methods screening and production of a large number of neutralized antibodies, is the best and fastest means to solve the current blood shortage and control of the epidemic.
Source: Global Network Reporter Hou Jiaxin Science and Technology Daily News (Journalist Tian Discipline)